Here we describe a transgenic mouse model [Crl:CD-1(ICR)BRTg(Cyp1a2-luc)Xen] using luciferase as a reporter for Cyp1a2 gene regulation. An 8.4-kilobase mouse Cyp1a2 promoter driving the firefly luciferase gene was microinjected into single-cell-stage CD-1 mouse embryos. A transgenic mouse line was selected based on basal and induced levels of the transgene in mouse liver by an in vivo bioluminescent imaging method. The basal levels of the luciferase reporter in liver were expressed much higher than other tissues, which correlated well with the endogenous Cyp1a2 mRNA tissue distribution. Male signals were about 23-fold higher than females in liver. However, the Cyp1a2 mRNA showed no gender difference. When mice were challenged with xenobiotics, the liver luciferase signal was induced to various degrees. At the doses we used, the relative effects were phenobarbital 4 2,3,7,8-tetrachlorodibenzo-p-dioxin 4 3-methylcholanthrene 4 benzo[a]pyrene and b-naphthoflavone. Induction of the Cyp1a2-luc reporter was generally consistent with the endogenous Cyp1a2 mRNA. However, phenobarbital induction was unexpectedly higher, while b-naphthoflavone induction of the reporter was much lower than that of the endogenous Cyp1a2 gene. Induction of the Cyp1a2-luc transgene by aryl hydrocarbons (Ah) in the CD-1 background was much less than that found in the Ah responsive C57BL/6 mice, while being similar to the nonresponsive DBA/2 strain. Sequence analysis of the CD-1 Ah receptor (AhR) cDNA clones demonstrated that consensus sequence was identical to some of the Ah-responsive strains such as BALB/C and CBA/J mice. The 104-kD AhR protein was not detectable in CD-1 mice, while the 97-kD AhR was detected in the C57BL/6 mice by Western blot using an AhR antibody. Low expression of the AhR in CD-1 mice could be in part responsible for low responsiveness to Ah compounds. The findings demonstrated the outbred CD-1 mouse is a low-responsive strain, and the Cyp1a2-luc transgenic CD-1 mice can be used for studying the regulation of the mouse Cyp1a2 gene in an Ah low-responsive strain in real time using the bioluminescent imaging approach.
Cytochrome P450 (CYP) enzymes, a superfamily of hemecontaining proteins, are involved in the metabolism of a variety of structurally diverse exogenous and endogenous compounds (Li et al., 1995; Shimada et al., 1994) . The CYP1 family, including members such as 1A1, 1A2, and 1B1, is involved in metabolizing many drugs as well as activating chemical carcinogens, mutagens, and other environmental pollutants (McManus et al., 1990; Pelkonen and Nebert, 1982) . Induction of CYP1 gene expression may play an important role in chemical-induced carcinogenesis (Nebert et al., 1987) and may also influence the therapeutic efficacy of some drugs that are metabolized by CYP1 enzymes.
The expression and regulation of CYP 1A genes among mammals is quite similar (Okey et al., 1994) . The Cyp1a2 gene is constitutively expressed in liver, while the Cyp1a1 is expressed in several tissues only after induction in mice (Kimura et al., 1986) . The mouse Cyp1b1 is constitutively expressed in liver, lung, and uterus (Savas et al., 1994) . Studies on the regulation of CYP1 genes have mainly focused on the CYP1A1 isoform. Regulation of the CYP1A2 gene is not clearly understood inmammals.Arylhydrocarbons(Ah)suchas2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), b-naphthoflavone (BNF), and 3-methylcholanthrene (3-MC) induced the mouse Cyp1a genes through a classic aryl hydrocarbon receptor (AhR) signaling pathway requiring interaction with AhR nuclear translocator (ARNT) and heat shock protein 90 (HSP90) . Some other compounds such as acenaphthylene, piperonyl butoxide, and phenobarbital utilize unidentified AhRindependent mechanisms in mice to induce Cyp1a2 gene (Ryu et al., 1996; Sakuma et al., 1999) . The human CYP1A2 promoter has been partially characterized. A response element including an AhR binding site and two AP1 sites have been identified approximately 2.2 kb upstream of the transcription start site of the human CYP1A2 gene (Quattrochi et al., 1998) . Nuclear factor-1, CCAT transcription factor, nuclear factor 1-like, and hepatic nuclear factor-1 binding sites and six E-box motifs in the human CYP1A2 promoter region are required for tissue-specific and constitutive expression (Chung and Bresnick, 1995; Pickwell et al., 2003; Zhang et al., 2000) .
We have previously used bioluminescent imaging approach to study in vivo transcription of the CYP3A4 gene in mice (Zhang et al., 2003 (Zhang et al., , 2004 . Since regulation of the CYP3A4 gene through orphan nuclear receptors such as pregnane X receptor and constitutive androstane receptor is so different from the CYP1A gene regulation through the AhR receptor, it is necessary to establish an in vivo model to study transcriptional effects of Ah on the CYP1A genes. The constitutive level of Cyp1a2 mRNA appears to be at least as high as the maximally induced mRNA level of Cyp1a1 (Gonzalez et al., 1984) . As a result, a smaller induction of Cyp1a2 over a high basal level can lead to a greater increase in the activation of carcinogens and clearance of drugs than that due to Cyp1a1 maximal induction. Due to the importance of Cyp1a2 induction and because the outbred CD-1 mouse strain is the most common mouse strain used in toxicology studies, we developed a transgenic model [Crl:CD-1(ICR)BR-Tg(Cyp1a2-luc)Xen] containing an 8.4-kb mouse Cyp1a2 promoter driving a luciferase reporter in the CD-1 mouse background. Basal expression of the transgene mimics the endogenous Cyp1a2 gene distribution in the transgenic mice. Both Ah and non-Ah compounds induced the reporter transgene in vivo. This model provides a unique tool to examine chemical compounds that may induce the mouse Cyp1a2 gene in a low-responsive strain.
MATERIALS AND METHODS
Generation of the Cyp1a2-luc transgenic line. A bacterial artificial chromosome (BAC) clone from 129/SVJ mouse I library containing the mouse Cyp1a2 promoter region was screened by PCR using primers 5 0 -CCATGTGAC-CAGCCACTTCACATTCC-3 0 corresponding to nucleotides À614 to À589 and5 0 -GCAGAGTTGTGGGAGTCAGTCCAG-3 0 correspondingtonucleotides 12 to 125 of the mouse Cyp1a2 promoter region (Incyte Genomics Inc.; St. Louis, MO). A 1.2-kilobase (kb) DNA fragment upstream of translational start was amplified from the BAC DNA by high-fidelity PCR using pfu DNA polymerase (Stratagene, La Jolla, CA) and primers 5 0 -CAGCATCCAGCTAT-GATATCAAGTGACC-3 0 and 5 0 -CAACCATGGATACCACTGCAGGG-GAAATGG-3 0 . This PCR product, starting from nucleotide À91 to the translational start where an NcoI restriction site was engineered, was fused to the firefly luciferase cDNA in pGL3-Basic vector (Promega, Madison, WI), resulting in a plasmid pGL3-Cyp1a2TB. This PCR clone was fully sequenced. An 8.4-kb SphI/XmaI DNA fragment from the BAC clone was subcloned into pGEM3Zf(1) (Promega, Madison, WI) with a SalI/MluI/XmaI/SalI linker at the SphI site. The 8.4-kb MluI/XmaI fragment was then fused to the XmaI site in the pGL3-Cyp1a2TB vector. The resulting vector pGL3-Cyp1a2 (Cyp1a2-luc) contains the 8.4-kb promoter region, the untranslated exon 1, and the 1.067-kb intron 1 of the mouse Cyp1a2 gene in front of luciferase cDNA. All the joints were confirmed by DNA sequencing. A SalI fragment from the pGL3-Cyp1a2TB vector was purified and then microinjected into single-cell-stage CD-1 mouse embryos, and the embryos were implanted into pseudopregnant mice.
Genotyping of Cyp1a2-luc transgene. Transgenic founders and offspring were identified by polymerase chain reaction (PCR) using luciferase primers Luc F (5 0 -GAAATGTCCGTTCGGTTGGCAGAAGC-3 0 ) and Luc R (5 0 -CCAAAACCGTGATGGAATGGAACAACA-3 0 ) as described by Zhang et al., 2003. Screening Cyp1a2-luc founders. For primary screening of each transgenic founder line, a group of three mice including both genders (one male and two females or two males and one female) were imaged for basal expression of the Cyp1a2-luc transgene. Lines were also tested for their response to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) at 100 mg/kg and 3-methylcholanthrene (3-MC) at 50 mg/kg. Mice were imaged daily for 3 days after injection. The criteria used for screening founding lines were: (1) high basal luciferase expression in liver and (2) upregulation of luciferase expression in liver by both TCDD and 3-MC injection. Five transgenic founding lines were screened, and one line was selected to fully characterize.
Chemicals. Dimethyl sulfoxide (DMSO), 3-methylcholanthrene (3-MC), phenobarbital (PB), benzo[a]pyrene (BP), and b-naphthoflavone (BNF) were purchased from Sigma-Aldrich (St. Louis, MO). 2,3,7,8-Tetrachlorodibenzop-dioxin (TCDD) was purchased from Cambridge Isotope Laboratories (Andover, MA).
Animal studies. Male and female Cyp1a2-luc transgenic mice at 8-12 weeks of age, in groups of three to five, were injected ip with a single dose of DMSO, TCDD dissolved in DMSO at 100 mg/kg, 3-MC suspended in DMSO at 50 mg/kg, saline, PB dissolved in saline at 100 mg/kg, corn oil, BP dissolved in corn oil at 10 mg/kg, BNF suspended in corn oil at 100 mg/kg. Mice were imaged as described below at T 5 0 (pretreatment), 3, 6, 9, 24, 48 , and 72 h after drug treatment.
In vivo imaging. In vivo bioluminescent imaging was performed as previously described (Contag et al., 1995) . The substrate luciferin was injected into the intraperitoneal cavity at a dose of 150 mg/kg body weight (30 mg/ml luciferin) approximately 5 min prior to imaging. Mice were anesthetized with isoflurane/oxygen and placed on the imaging stage. Ventral and dorsal images were collected for 1 s using the IVIS 1 Imaging System 100 (Xenogen, Alameda, CA). Photons emitted from the liver region were quantified using LivingImage 1 software (Xenogen, Alameda, CA).
Ex vivo luciferase assay. Liver, duodenum, kidney, spleen, lung, heart, brain were homogenized and sonicated using a tissue disrupter (Sonic Dismembrator 60, Fisher Scientific, Pittsburgh, PA) in 800 ml of PBS buffer. Luciferase activity was determined over a 20-s integration time using the Luciferase Assay System and a TD 20/20 Luminometer (Promega, Madison, WI). Luciferase activity was normalized to relative light units (RLU) per mg of total protein in the homogenates. Protein content was measured using Bradford Reagent (Sigma-Aldrich, St. Louis, MO).
Effects of chemicals on the luciferase activity ex vivo. A female Cyp1a2-luc liver was homogenized in PBS solution. DMSO, TCDD at 100 mg/l, 3-MC at 50 mg/l, saline, PB at 100 mg/l, corn oil, BP at 10 mg/l, or BNF 100 mg/l was added to 100 ml of liver homogenate and the mixtures were incubated in room temperature for 15 min. Luciferase activity was determined as described above.
Northern Analysis
Tissue distribution of Cyp1a2 mRNA. Seven tissues including liver, duodenum, kidney, spleen, lung, heart, and brain from both male and female Cyp1a2-luc transgenic mice (three per group) were also analyzed by Northern blotting for tissue distribution. A C57BL/6 female mouse treated with TCDD at 100 mg/kg was used as a positive control. Total RNA was extracted using RNAWIZ TM Reagent (Ambion, Inc., Austin, Texas). Fifteen mg of total RNA from each sample and 4mg of RNA from TCDD-treated animals were analyzed. A single-strand antisense full-length Cyp1a2 RNA probe was labeled using Strip-EZ TM RNA StripAble TM RNA Probe Synthesis and Removal Kit (Ambion, Inc., Austin, Texas). The blot was hybridized and detected following the instructions of the manufacturer using the BrightStar BioDetect TM Nonisotopic Detection Kit (Ambion, Inc., Austin, Texas).
Drug effects on the Cyp1a2 mRNA. Cyp1a2-luc transgenic female mice (two per group) were treated as described in the Animal Studies section. C57BL/6 female mice (two per group) treated with 100 mg /kg of TCDD and 50 mg/kg of 3-MC as positive controls. Mouse livers were removed and quickly frozen in liquid nitrogen 9 h after treatments. Fifteen mg of total RNA from each sample were analyzed using the Cyp1a2 probe. A blot with the sample loadings was hybridized with a b-actin antisense RNA probe.
Western analysis. Liver samples from CD-1 and C57BL/6 male mice (3 mice per group) were homogenized and sonicated in cold PBS solution. Fifty mg of protein from each cytosolic fraction were separated on a 7 % SDS-polyacrylamide gel and then transferred to a nitrocellulose membrane (Bio-Rad, CA). AhR protein was detected using primary rabbit polyclonal antisera against a human AhR peptide (Santa Cruz Biotechnology, Santa Cruz, CA) and peroxidase-conjugated secondary antibody goat-anti-rabbit IgG (Bio-Rad, Hercules, CA). Chemiluminescent detection reagents were purchased from Amersham Biosciences, Piscataway, NJ.
Cloning of AhR cDNA from CD-1 mouse mRNA. Total RNA was isolated from a pool of 20 female and 29 male CD-1 mouse liver samples using RNAWIZ TM Reagent (Ambion, Inc., Austin, Texas). The mRNA was purified using the MicroPoly(A)Pure TM Kit (Ambion, Inc., Austin, Texas). Since we had difficulties amplifying the entire AhR cDNA, we cloned the amino-terminal (N-terminal) portion (1-1254, start codon to BamHI site) and carboxyl-terminal (C-terminal) portion (1255-2547, BamHI site to stop codon) of the AhR cDNA separately. The AhR-TOP-HindIII primer 5 0 -CCCAAGCTTATGAG-CAGCGGCGCCAACATCAC-CTATGCC-3 0 corresponding to nucleotides 1-30 and the AhR-R2 primer 5 0 -CCAACTCCCGCACTTGCTCACG-GAGCCC-3 0 corresponding to nucleotides 1434 to 1461 were used to amplify the N-terminal region of AhR cDNA from the mRNA pool by reverse transcription polymerase chain reaction (RT-PCR) using ProSTAR TM HF Single-Tube RT-PCR System (High Fidelity) Kit (Stratagene, La Jolla, CA). The HindIII/ BamHI fragment from PCR product was cloned into the pGEM3Zf(1) vector (Promega, Madison, WI). The C-terminal region of the AhR cDNA was amplified using the AhR-F1 primer 5 0 -GGAGAGGCTGTGTTGTACGAGATCTCCAG-3 0 corresponding to nucleotides 1207-1235 and AhR-BOT-XmaI primer 5 0 -TCCCCCGGGCTACAGGAATCCACCAGGTGTGATATCGGG-3 0 . The BamHI/XmaI fragment from the PCR product was cloned into the pGEM3Zf (1) vector. Five N-terminal clones (N #1, N #5, N #8, N #10, and N #11) and six Cterminal clones (C #3, C #5, C#6, C#7, C#9, and C #11) were sequenced by the Stanford PAN Facility, Stanford, CA.
Statistical analysis. Data are presented in the text and figures as means 6 standard error about the mean. Induction of the luciferase signal was analyzed by an analysis of variance with post hoc t-tests to evaluate the difference between luciferase activity at the 0 time point and each subsequent time point. In order to determine if there was an overall difference in response to drug compared with their solvents, a multivariate analysis of variance (MANOVA) model was used comparing the drug response for each drug with the response to vehicle. Female and male data were analyzed separately. Statistical tests were performed using the Statview statistical package (Version 5.0.1; SAS Institute, Cary, NC).
RESULTS

Gender Difference in Basal Expression of the Cyp1a2-luc Reporter
Reporter transgenic mice were generated using a reporter construct containing 8.4 kb of the mouse Cyp1a2 promoter driving the luciferase gene. Five founding lines were screened by in vivo bioluminescent imaging. Transgenic mice expressed high luciferase signals in the liver region in all five lines. One line was selected for further study. Male mice expressed luciferase activity about 23-fold higher than age-matched females (Fig. 1A) . Basal levels of the Cyp1a2-luc expression were studied in seven tissues including liver, duodenum, kidney, spleen, lung, heart, and brain in both male and female mice at age of 12 weeks (n 5 3). Ex vivo luciferase assay showed that male liver homogenate signals were 26-fold higher than female signals (Fig. 1B) , consistent with the in vivo imaging results. Low levels of luciferase activity were also detected in other tissues in both genders, with higher signals in males than in females (23-fold higher in duodenum; 9-fold in kidney; 6-fold in lung; 14-fold in spleen; 9-fold in heart; 7-fold in brain). Liver signals were much greater than other tissues (about 4000-fold higher than duodenum signals).
To compare tissue distribution of the Cyp1a2-luc reporter expression to the mouse endogenous Cyp1a2 mRNA, the same seven tissues from both male and female Cyp1a2-luc transgenic mice (n 5 3) analyzed for luciferase activities were also processed for Northern analysis. The antisense Cyp1a2 RNA probe used also hybridized with Cyp1a1 mRNA. In CD-1 transgenic mice, the Cyp1a2 mRNA was detected at high levels in the liver (Fig. 1C) , while other tissues were not detectable. With longer exposure, we also noted that the Cyp1a2 mRNA was detected in heart tissue, and the basal level of Cyp1a1 mRNA was only detectable in the duodenum samples. Unlike the Cyp1a2-luc reporter, the endogenous Cyp1a2 mRNA showed no gender difference (Fig. 1C) .
In Vivo Drug Responses of the Cyp1a2-luc Reporter and the Endogenous Cyp1a2 Genes
We chose five different known mouse Cyp1a2 inducers to study the effects of drugs on transcriptional regulation of the Cyp1a2-luc reporter in vivo. Males and females in separate groups were challenged with 2,3,7,8-tetrachlorodibenzo-pdioxin at 100 mg/kg, 3-methylcholanthrene at 50 mg/kg, phenobarbital at 100 mg /kg, benzo[a]pyrene at 10 mg/kg, and b-naphthoflavone at 10 mg/kg body weight. DMSO, saline, and corn oil were used as vehicle controls for these drugs. Mice were imaged from the ventral side at 0 (before injection) and 3, 6, 9, 24, 48 and 72 h after a single administration of drug.
Injection of these drugs produced significant induction to various degrees of the Cyp1a2-luc transgene in vivo in both male ( Fig. 2A) and female ( Fig. 2B ) mice, and both genders showed very similar response patterns. At the peak time and doses used, PB induced the Cyp1a2-luc reporter strongest with 10.9-fold induction in females and 6.4-fold induction in males, and TCDD increased the reporter signal moderately (7.1-fold in females; 3-fold in males). The 3-MC effect was marginal. The BP and BNF had no significant effect on the reporter signal. The PB effect appeared to be transient, with peak response between 6 and 9 h after injection, and signals returned to background completely at the 48-h time point. The TCDD effect was observed at 6 h after injection and was sustained for a longer period of time.
To confirm the in vivo patterns of drug responses, female Cyp1a2-luc mice (n 5 2) were treated as described above. Livers were collected 9 h after drug administration and analyzed for luciferase activity. Phenobarbital, TCDD, 3-MC, and BP induced the Cyp1a2-luc transgene about 18.7-, 7.3-, 5.3-, and 1.9-fold, respectively, while BNF reduced luciferase signal about 40% (Fig. 3A) . The endogenous Cyp1a2 mRNA levels REGULATION OF MOUSE CYP1A2 IN TRANSGENIC REPORTER MICE from the same liver samples were also analyzed by Northern hybridization using the antisense Cyp1a2 RNA probe (Fig. 3B ). C57BL/6 female mice treated with TCDD and 3-MC were also included as positive controls. All compounds induced the endogenous gene. Induction of the mouse Cyp1a2 mRNA by TCDD, 3-MC, and BP correlated well with the ex vivo luciferase activity.
However, phenobarbital, which induced strongest luciferase signals, only increased the Cyp1a2 mRNA slightly. BNF, which reduced ex vivo luciferase signals, strongly induced the Cyp1a2 mRNA (Fig. 3B) . To test if drugs affected the luciferase enzymatic activity, liver homogenates were incubated with each drug for 15 min at room temperature, and luciferase activity was Baseline reporter activities (photons per second) in both genders from the ventral surface in the region of the liver are presented as mean 6 standard deviation (n 5 27). Panel B. Ex vivo luciferase signal was measured in isolated organs including liver, duodenum, kidney, lung, spleen, heart, and brain in both male and female mice (12 weeks old) using a luminometer. Data are presented as relative light units (RLU) per mg of protein and shown as mean 6 standard error using three mice per group. Panel C. Tissue distribution of the Cyp1a2 mRNA was analyzed by Northern hybridization. Fifteen mg of total RNA from each sample were analyzed using an antisense Cyp1a2 RNA probe. Data are shown from representative male and female transgenic mice. Cyp1a2 mRNA was expressed at the highest level in liver and not detectable in other tissues. Four mg of liver RNA isolated from a female C57BL/6 mouse treated with 100 mg/kg of TCDD was loaded as a positive control. *** indicates significant difference between female and male mice at p 5 0.001. 300 assayed. BNF strongly inhibited the luciferase activity (about 96%), and 3-MC inhibited luciferase activity about 25%.
Low Responsiveness to Aryl Hydrocarbons in CD-1 Mice
May Be Due to Low Expression of Ahr, but Not Ahr Variants
Responses to typical Cyp1a2 inducers such as TCDD, 3MC, BP, and BNF in the Cyp1a2-luc transgenic mice were much lower than those reported in an Ah-responsive strain C57BL/ 6, but similar to that in an Ah-nonresponsive strain DBA/2 (Moriguchi et al., 2003) . It has been reported that C57BL/6 mice are more responsive to Ah than DBA/2 mice due to a conservative amino acid change from Ala 375 (C57BL/6) to Val 375 (DBA/2) (Ema et al., 1994) . We speculated that the low responses to Ah in CD-1 mice might be also determined by a mutated AhR similar to that in DBA/2 mice. In order to compare CD-1 AhR sequence to other mouse strains, we cloned and sequenced AhR cDNA from the CD-1 mouse strain (GenBank Accession Numbers AY662080-AY662090). Considering that the CD-1 mouse, an outbred strain, contains a high level of genetic variation, an mRNA pool made from 20 female and 29 male liver samples was used to amplify the AhR cDNA using high-fidelity pfu DNA polymerase. We cloned the N-terminal portion (nucleotides 1-1254, start codon to BamHI site) and C-terminal portion (nucleotides 1255-2547, BamHI site to stop codon) of the AhR cDNA separately, since we had difficulty amplifying the entire cDNA. We sequenced five individual N-terminal clones and six C-terminal clones. One N-terminal clone, N #5, had a deletion of 104 nucleotides corresponding to nucleotides 251-354, and one C-terminal clone, C#5, had a fivenucleotide insertion at 1692 (Fig. 3) , resulting in frame-shifts of translation. The deduced amino acid sequences revealed 11 unique amino acid point mutations in the entire 848 amino acid regions from these clones when aligned with the consensus AhR sequence derived from 13 inbred mouse strains Male Cyp1a2-luc mice at ages of 8-12 weeks were challenged ip with dimethyl sulfoxide (DMSO), 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) dissolved in DMSO at 100 mg/kg, 3-methylcholanthrene (3-MC) suspended in DMSO at 50 mg/kg, saline, phenobarbital (PB) dissolved in saline at 100 mg/kg, corn oil, benzo[a]pyrene (BP) dissolved in corn oil at 10 mg/kg, b-naphthoflavone (BNF) suspended in corn oil at 100 mg/kg. Mice were imaged at T 5 0 (pretreatment), 3, 6, 9, 24, 48, and 72 h after drug treatment. Photons per second were quantified from the liver regions of animals. Induction of the reporter by compounds relative to its vehicle is presented as mean 6 standard error (n 5 6-9). Panel B. The time course of response in female mice treated as described in Figure 2A . * , ** , and *** indicate significant differences from respective vehicle controls at p 5 0.05, p 5 0.005, and p 5 0.001, respectively. (Thomas et al., 2002) . Nine of these amino acid variants were also found in the inbred AhR sequences, although at different positions (Fig. 4, Table 1 ). Two additional sequences variants, Phe 348 in all four clones and Thr 758 in four of five clones, are also found in the CBA/J, C3H/HeJ, BALB/c, and A/J strains (Fig. 4) . The consensus peptide sequence of CD-1 AhR cDNA is identical to the AhR sequences of BALB/C and CBA/J mice, both AhRresponsive strains. All CD-1 AhR clones have the Ala 375 found in all Ah responsive strains.
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Another reason for the low responsiveness of CD-1 mice may be low expression of AhR protein (Bigelow and Nebert, 1986; Jana et al., 1998) . Liver cytosols from female CD-1 and C57BL/ 6 mice were analyzed by Western blotting using an AhR antibody. The antibody was raised in rabbit against a recombinant peptide corresponding to amino acids 637-848 of human AhR protein. Because the deduced CD-1 AhR peptide consists of 848 amino acids and C57BL/6 AhR has 805 amino acids, we expected a 104-and 97-kD AhR protein in CD-1 mice and C57BL/6 mice, respectively. The antibody cross-reacted to the 97-kD AhR protein from C57BL/6 liver samples, but no cross-reactivity was observed in the 104 kD region from the CD-1 mouse liver samples (Fig. 5) . A fainter 97-kD band was also found in CD-1 samples.
DISCUSSION
The function of the 8.4-kb mouse Cyp1a2 promoter was examined in transgenic mice, and basal activity of the promoter was most active in the liver compared to other tissues. This result was confirmed by the Northern analysis and consistent with previous studies in both human and mice (Kimura et al., 1986; Shimada et al., 1989) , suggesting transcription elements required for basal and tissue-specific expression are included in the 8.4-kb region of the promoter. Although it has been reported that the Cyp1a2 gene is exclusively expressed in liver, we detected the Cyp1a2-luc signals in all extrahepatic tissues tested including kidney, duodenum, spleen, lung, heart,
FIG. 3.
Comparison of the Cyp1a2-luc reporter and the endogenous Cyp1a2 gene in response to drugs: Panel A. Cyp1a2-luc transgenic female mice (n 5 2 per treatment) were treated as described in Figure 2 . Livers were removed 9 h after drug injection, and ex vivo luciferase activities (RLU/mg protein) were measured. Panel B. Northern analysis of induction of the Cyp1a2 mRNA. Fifteen mg of total RNA from the same liver samples were analyzed by Northern blotting using the antisense Cyp1a2 RNA probe. C57BL/6 female mice treated with TCDD and 3-MC were used as positive controls. 4 . Polymorphisms of CD-1 AhR peptide sequences (GenBank Accession Numbers: AY662080-AY662090): The AhR cDNA clones were generated from a pool of CD-1 liver mRNA by high fidelity RT-PCR. The deduced amino acid sequences of individual clones were aligned with the consensus AhR sequence (bold letters) derived from 13 inbred mouse strains (Thomas et al., 2002) . Eleven bold italic letters indicate unique amino acid mutations in individual CD-1 AhR clones. Italic letters F and T indicate amino acid changes found in multiple CD-1 AhR clones. The Phe 348 in all four clones and Thr 758 in four of five clones are also found in CBA/J, C3H/HeJ, BALB/c, and A/J strains. * indicates the position of an amino acid residue different from the consensus inbred strain sequence. The underlined region indicates the location of deletion in the N #5 AhR cDNA clone, and the arrow indicates the 5-nucleotide insertion in the C #5 AhR cDNA clone.
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and brain at much lower levels. Possibly due to the lack of sensitivity of Northern analysis, basal expression of the Cyp1a2 in extrahepatic tissues was not detected. Low levels of Cyp1a2 expression in extrahepatic tissues detected by the sensitive luciferase assay implies that the CYP1A2 enzyme may also be important in local detoxification of aromatic hydrocarbons in addition to liver detoxification.
It is very interesting that basal expression level of the Cyp1a2-luc was much higher in male mice than in female mice in multiple founding lines, while the endogenous Cyp1a2 mRNA showed no gender difference. Although previous studies have demonstrated that males have higher demethylation activity of caffeine by CYP1A2 protein than females in three of six inbred mouse strain (Casley et al., 1997) , the CD-1 mouse Cyp1a2 mRNA level appeared to be independent of genders. It is possible that the Cyp1a2 promoter isolated form 129/SVJ genome confers the gender differences in the reporter expression. It has been reported that 17b-estradiol suppresses the 
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CYP1A expression in rainbow trout liver cells through the estrogen receptor (Navas and Segner, 2001) . In all five founding lines that were screened, there was a consistent gender difference, with the male mice having higher basal level of the transgene expression. Therefore, we believe that this gender difference is not due to effects of integration sites of the transgene.
The Cyp1a2-luc transgenic animal model that we have developed allows us to follow induction of the transgene in vivo over time using the IVIS 1 imaging system. Phenobarbital, a classic inducer of CYP1A, CYP2, and CYP3A genes, upregulated strongly the reporter in both genders, and the peak response was 6-9 h after a single dose of drug treatment. It has been reported that phenobarbital induces the mouse Cyp1a2 about 1.5-to 3-fold independent of AhR (Sakuma et al., 1999) , which correlated well with our Northern result. It appears that phenobarbital highly activates the Cyp1a2-luc transgene, but stimulates only slight induction of the endogenous Cyp1a2 mRNA. This discrepancy could be due to the fact that the transgene was integrated into a genomic locus where a phenobarbital-responsive element(s) is nearby. It is also possible that phenobarbital-responsive elements exist in the promoter that was isolated from 129/SVJ mice. Females responded to phenobarbital treatment slightly more than males, which may be due to the lower basal background signals.
TCDD, 3-MC, BP, and BNF are prototypic aryl hydrocarbons that induce the Cyp1a1 and Cyp1a2 genes in mice through the classic AhR signaling pathway . However, we only observed about 3-and 7-fold induction by a very high dose of TCDD (100 mg/kg) in males and females, respectively, which is much less induction compared to the 20-to 30-fold induction at 10 mg/kg observed in a previous study in C57BL/6 mice (Okino et al., 1992) . Our Northern data clearly showed that the Cyp1a2 mRNA in CD-1 mice induced by TCDD and 3-MC was much less than that in C57BL/6. In the rats, other potent inducers like 3-MC, BP, and BNF that induced the CYP1A2 gene transcription about 50-fold (Pasco et al., 1993) had no effect in the CD-1 Cyp1a2-luc reporter mice. It is clear that regulation of the CYP1A2 gene in rats is mainly transcriptional, as demonstrated by comparing Northern blotting and nuclear run-on analyses (Pasco et al., 1993) , rather than due to posttranscriptional accumulation of CYP1A2 mRNA proposed by Pasco et al. (1988) and Silver and Krauter (1988) . We could not detect BNF induction of the reporter transgene, but a good induction of the Cyp1a2 mRNA. This difference may be due to the observations that BNF is such a strong luciferase enzymatic inhibitor and that it negates the BNF induction of luciferase expression. Marginal induction by 3-MC may also be due to inhibition of the luciferase activity. Therefore, one should first determine if compounds have effects on the luciferase enzymatic activity before testing in vivo effects using the model.
It has been reported that genetic variations of AhR in mice lead to differences in regulation of Cyp1a genes in response to aromatic hydrocarbon inducers (Gonzalez et al., 1984; Nebert et al., 1975 Nebert et al., , 1982 . The C57BL/6 strain is the prototypical Ah-responsive mouse, possessing a high-affinity receptor, while the DBA/2 strain is the prototypical Ah-nonresponsive mouse, with a low-affinity receptor. Polymorphic forms of 
*The unique amino acid mutations from 13 inbred mouse strains were analyzed from sequences published by Thomas et al., 2002 . The numbers in parentheses indicate the frequency of mutations.
a Mutations only found in the CD-1 mouse strain. b Reverse mutations compared to other inbred mouse strains.
FIG. 5.
Comparison of AhR expression between CD-1 and C57BL/6 mice: Liver cytosolic fractions from female CD-1 and C57BL/6 mice (n 5 2 per treatment) were separated by a 7% SDS-PAGE. AhR protein was detected by Western blot using a polyclonal AhR antibody.
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mouse AhRs have been isolated from responsive C57BL/6 and nonresponsive DBA/2 and other mouse strains (Ema et al., 1992 (Ema et al., , 1994 Thomas et al., 2002) . TCDD, a potent Cyp1a inducer, induced Cyp1a1 and Cyp1a2 genes in both C57BL/6 and DBA/2, with a lower response in DBA/2 (Gonzalez et al., 1984; Okey et al., 1989) . 3-MC had no effect on both Cyp1a1 and Cyp1a2 genes in the DBA/2 strain, while both genes were induced 15-to 20-fold in the C57BL/6 strain (Gonzalez et al., 1984) . 3-MC and BNF also induced rat CYP1A2 gene about 10-fold (Kawajiri et al., 1984) . Based on the relatively low induction of the Cyp1a2-luc transgene and the endogenous Cyp1a2 mRNA compared to C57BL/6 mice, we conclude that CD-1 strain is a poor Ah-responsive mouse strain, the first nonresponsive outbred mouse strain described. In another preliminary study, 30 mg/kg 3-MC induced the CYP1A1-luc transgene (human CYP1A1 promoter) about 313-fold in FVB female mice, an Ah-responsive strain, while 50 mg/kg 3-MC only induced the CYP1A1-luc about 103-fold in CD-1 female mice. These data further indicated that the CD-1 mice are less sensitive to Ah compounds.
To explain the low responsiveness in CD-1 mice, we speculated that there might be a similar mutation Ala 375 to Val 375 in the CD-1 AhR as in DBA/2 strain (Ema et al., 1994) . However, sequence analyses of the CD-1 AhR cDNA demonstrated that the consensus sequences of polymorphic forms of the CD-1 AhR are identical to the responsive strains Balb/C and CBA/J with a normal Ala 375 . Point mutations found in CD-1 AhR individual clones may not play roles in determining the responsiveness, because most of these mutations have been found in other inbred strains, and no report shows that these positions are crucial for AhR function.
Since it has been reported that the low-or nonresponsive mouse strains express low levels of AhR protein (Bigelow and Nebert, 1986; Jana et al., 1998) , we compared the AhR levels between CD-1 and C57BL/6 mice by Western blot. No detectable 104-kD AhR protein in CD-1 mice suggests that the low responsiveness to Ah compounds may be due to the low expression of AhR protein. Although CD-1 livers also showed a little cross-reactivity at the 97-kD region, the intensity was much less than that in C57BL/6 livers, and therefore, that could just be nonspecific binding. Because the promoter for the reporter transgene was isolated for 129/SVJ mouse strain and this strain is an Ah-nonresponsive strain, this promoter region may have an imperfect AhR-responsive element(s) that leads to low induction. It also possible that additional responsive elements beyond the 8.4-kb promoter region are required for maximal induction of the Cyp1a2 gene. We cannot exclude possibilities that low responsiveness is due to mutations in other nuclear factors such as ARNT, HSP90, and AhR repressor. A point mutation in ARNT from mutant mouse Hepa-1c1c7 cells leads to lowaffinity binding to xenobiotic response element (NumayamaTsuruta et al., 1997) , and a polymorphism of human ARNT has also been reported (Scheel et al., 2002 ). An AhR repressor protein was also identified which inhibits function of AhR (Mimura et al., 1999) . Recently, a humanized AhR knock-in mouse model demonstrated that humanized AhR mice responded to drugs in a fashion more similar to the nonresponsive DBA/2 strain rather than the C57BL/6 strain (Moriguchi et al., 2003) , suggesting the DBA/2 strain may be a better model to assess AhR-mediated toxic effects of compounds.
In summary, we have developed a Cyp1a2-luc transgenic reporter mouse model containing an 8.4-kb mouse Cyp1a2 promoter region driving a firefly luciferase cDNA in the CD-1 mouse background. Male mice expressed the Cyp1a2-luc transgene at higher levels than female mice. Phenobarbital and TCDD induced the reporter in liver, while the 3-MC effect was marginal. BP and BNF had no effect. These reporter mice responded to Ah compounds with sensitivity similar to DBA/2 and humanized AhR C57BL/6 mice (Moriguchi et al., 2003) and may predict human CYP1A2 responses in vivo.
